Alexander Vandell

Alexander Vandell, PharmD PhD, currently serves as the Senior Director of Clinical Development at Karuna Therapeutics, a position held since November 2020. Previously, Vandell was the Vice President of Clinical Research at Tyme Inc. from October 2018 to November 2020, contributing to oncology drug development from pre-clinical stages through Phase 3. Earlier experience includes roles at Daiichi Sankyo, Inc., where Vandell advanced from Senior Scientist in Clinical Pharmacogenomics to Associate Director in Specialty Medicine Development, and at the University of Florida as a Post-Doctoral Fellow specializing in Pharmacogenomics. Academic credentials include a PhD in Biomedical Science (Neuroscience) from Mayo Clinic Graduate School and a PharmD from The University of Georgia. Vandell's research expertise encompasses clinical pharmacology, translational medicine, and personalized medicine strategies, specifically within oncology, cardiovascular, and neuroscience fields.